BIOMAT Database Logo BIOMAT Database Logo

[Initial results with a new cytostatic (Ro 4-6467) in 2 cases of Hodgkin's disease]. 1967

J M Leitão, and S N Magalhães, and S P de Jesus

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J M Leitão, and S N Magalhães, and S P de Jesus
[A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
July 1966, Revista brasileira de medicina,
J M Leitão, and S N Magalhães, and S P de Jesus
PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).
December 1963, Cancer chemotherapy reports,
J M Leitão, and S N Magalhães, and S P de Jesus
[ON THE EFFECT OF A NEW CYTOSTATIC (RO-4-6467) ON THE INCORPORATION OF LABELLED GLYCINE IN TUMOR CELLS].
January 1964, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
J M Leitão, and S N Magalhães, and S P de Jesus
[THE PHARMACOLOGICAL EFFECTS OF THE CYTOSTATIC RO 4-6467 (CLINICAL ASPECTS, HEMATOLOGY AND CYTOLOGY)].
January 1964, Archivos del Instituto de Farmacologia Experimental (Medicina),
J M Leitão, and S N Magalhães, and S P de Jesus
[Effect of a methylhydrazine derivative, Ro 4-6467, in Hodgkin's disease, in other malignant lymphomas and in leukemias].
June 1965, European journal of cancer,
J M Leitão, and S N Magalhães, and S P de Jesus
[ON THE PROBLEM OF THE BIOCHEMICAL EFFECT OF A NEW CYTOSTATIC AGENT, RO 4-6467, FROM THE CLASS OF METHYLHYDRAZINE DERIVATIVES].
January 1964, Chemotherapia,
J M Leitão, and S N Magalhães, and S P de Jesus
Histology of rat placentas treated with methylhydrazine Ro 4-6467.
January 1990, Boletin de estudios medicos y biologicos,
J M Leitão, and S N Magalhães, and S P de Jesus
[Treatment of lymphomas with a derivative of methylhydrazine (Ro 4-6467). Clinical study on 34 cases].
January 1967, Sangre,
J M Leitão, and S N Magalhães, and S P de Jesus
[THE TREATMENT OF NEOPLASTIC PROCESSES WITH A NEW PRODUCT DERIVED FROM METHYL-HYDRAZINE (RO 4-6467)].
November 1964, Revista clinica espanola,
J M Leitão, and S N Magalhães, and S P de Jesus
EFFECT OF CYCLOPHOSPHAMIDE AND OF RO 4-6467 ON LEPROSY.
April 1965, Lancet (London, England),
Copied contents to your clipboard!